BioAtla
BCAB
80 hedge funds and large institutions have $30.4M invested in BioAtla in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 16 increasing their positions, 28 reducing their positions, and 29 closing their positions.
500% more call options, than puts
Call options by funds: $78K | Put options by funds: $13K
0.14% less ownership
Funds ownership: 1.06% → 0.92% (-0.14%)
7% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 29
2% less funds holding
Funds holding: 82 → 80 (-2)
43% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 28
65% less capital invested
Capital invested by funds: $87.2M → $30.4M (-$56.8M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.85M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.51M |
| 3 |
SAM
Scion Asset Management
Saratoga,
California
|
+$1.51M |
| 4 |
Goldman Sachs
New York
|
+$742K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$385K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$4.73M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$4.03M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.55M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.23M |
| 5 |
Renaissance Technologies
New York
|
-$882K |
BCAB Hedge Fund Activity: Q2 2024 in Review
80 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in BioAtla (BCAB) for Q2 2024, worth a combined $30.4M — down 65% from $87.2M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of BCAB and 27 opened new positions — a net loss of 2 holders — while 28 trimmed existing stakes and 16 added.
The largest buyer was Millennium Management, adding an estimated $1.85M. The largest seller was BlackRock, cutting an estimated $4.73M.
- 80 institutional investors held BioAtla (BCAB) as of Q2 2024, down from 82 in Q1 2024.
- Funds reported $30.4M of BioAtla stock for Q2 2024, down 65% quarter-over-quarter.
- 27 funds opened new BioAtla positions in Q2 2024 and 29 closed out, a net change of -2 holders.
- The largest BioAtla buyer in Q2 2024 was Millennium Management, an estimated $1.85M added.
- The largest BioAtla seller in Q2 2024 was BlackRock, an estimated $4.73M sold.
Based on aggregated 13F filings for Q2 2024.